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Abstract
Background: Resection of aggressive benign or malignant tumours of the proximal fibula are difficult due to the high number of 
surrounding anatomical compartments and close association with many important neurovascular and functional structures. For the 
same reasons malignant tumours behave differently in this area. Before the 1980s results were poor. With the introduction of neo-
adjuvant chemotherapy and limb salvage surgery, Malawer described a technique of local en bloc resection. This study presents the 
oncological and functional results of a case series using this technique.
Patients and methods: A retrospective folder review of 14 patients was done. Six patients with a large active, an aggressive benign 
or a low-grade malignant tumour had a Malawer type I marginal resection, and eight patients with a stage IIB malignant sarcoma had 
a Malawer type II wide intracompartmental resection sacrificing the common peroneal nerve. The follow-up at a median of 38 months 
included the imaging, histology and a functional MSTS score.
Results: The median age of the type I resections was 42.5 years; giant cell tumour was the commonest tumour (50%); and the median 
functional MSTS score at follow-up was 29. The median age of the type II resections was 12 years; osteoblastic osteosarcoma was 
the commonest tumour (75%); and the median functional MSTS score was 26. All type II resections achieved clear margins at the 
initial surgery and there were no recurrences or metastases in either group. There were no wound complications and no vascular 
complications in spite of sacrificing the tibialis anterior artery in some type I and all type II resections, and the peroneal artery in type 
II resections. No patient complained of knee instability. The main functional impairment was due to loss of common peroneal function 
which required an AFO in some patients and a tibialis posterior tendon transfer in one patient.
Conclusions: Resection of benign and malignant tumours of the proximal fibula achieved good cure rates and functional results, 
despite the sacrifice of the common peroneal nerve.
 
Level of evidence: Level 4
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Introduction
Primary bone tumours of the proximal fibula are rare, comprising 
only 2.5% of bone tumours.1 Approximately half of these tumours 
are malignant.1 Abdel et al.2 found an incidence of malignant 
tumours of the proximal fibula of 1.2 per year (112 tumours at the 
Mayo Clinic from 1910 to 2007). 
Although uncommon, the treatment has large functional and 
oncological implications for the patient. Half of the tumours of the 
proximal fibula are malignant and require wide local excision. The 
proximal fibula is in close proximity to many important neurovascular 
and musculoskeletal compartments. Malawer3 hypothesised that 
because of the anatomical peculiarities of the proximal fibula, 
tumours behave differently in this area. The proximal fibula, with 
multiple muscle attachments and thin cortices, allows early cortical 
extension and direct invasion of surrounding structures, rather 
than the usual pushing growth and respect of fascial boundaries of 
sarcomas in other areas of the body. 
The results of resection in the past were poor, showing high rates 
of re-operation for contaminated margins, and local recurrence, 
poor prognosis and functional results. As a result many centres 
advised amputation for malignant lesions of the proximal fibula.4 
The concept of performing limb salvage surgery was revisited in 
the 1980s and was pioneered by Pritchard et al.,5,6 Rosen et al.,7  
Bacci and Campanacci et al.,8 and Malawer and Zaleskie.9 All 
showed good functional outcomes and equivalent cure rates using 
newer limb salvage techniques. Malawer in 19843 described the 
specific approach and technique for resection of tumours of the 
proximal tibia. 
This paper presents the curative and functional results of our 
series of Malawer-type I marginal resections for large active or 
aggressive benign tumours and low-grade sarcomas, and Malawer 
type II wide intra-compartmental resections for high-grade bone 
sarcomas.
Methods and materials
A retrospective folder review was performed from January 1995 
to January 2017. Fourteen patients who underwent limb salvage 
for a proximal fibula neoplasm were included. This group was then 
subdivided into those who had a type I Malawer resection for a 
large active or aggressive benign tumour or low-grade malignant 
bone sarcoma, and those who received a type II resection for a 
stage IIB or higher10 primary bone sarcoma (Figure 1). Exclusion 
criteria included incomplete records and patients who were lost to 
follow-up. Two patients were excluded. 
MRI (Figure 2) or CT was used to assess the lesion, patency 
of the relevant vasculature and position of the common peroneal 
nerve. CT angiography was used in selected cases if assessment 
of the vasculature was equivocal or inadequate on the MRI. 
Diagnosis was confirmed with open or 14-gauge needle biopsy in 
the operative theatre. For the stage IIB type II resections, patients 
received neo-adjuvant chemotherapy and no pre-operative 
radiotherapy. Adjuvant chemotherapy was commenced three to six 
weeks post-operatively.7 The patients who had type I resections 
received neither chemotherapy nor radiotherapy. 
Follow-up was performed by the oncologists for the high-
grade malignant lesions and included a chest X-ray and clinical 
examination every three months for the first two years, six monthly 
for years 2–5 and annually for years 5–10, at which point the patient 
was discharged. The patients with aggressive benign lesions or low-
grade malignant sarcomas were followed up by the orthopaedic 
surgeons with clinical examination and X-ray of the lesion every 
six months until discharge at two years. A Musculoskeletal Tumour 
Society (MSTS) score11 was performed at final follow-up.
At a median follow-up of 38 (6–123) months the clinical notes 
including the MSTS score, imaging and histology were reviewed. 
Descriptive statistical methods are used to present our findings. 
No further statistical methods were deemed necessary as no 
comparisons are being made and patient numbers are small.
Figure 1. Antero-posterior X-ray of 
the proximal lower leg of a 12-year-old 
female patient with an osteoblastic 
osteosarcoma of the proximal fibula 
after neoadjuvant chemotherapy
Figure 2. T2-weighted MRI pictures, 
coronal (a), sagittal (b) and axial (c), with 
a proximal fibula high-grade sarcoma
Figure 3. Illustration showing patient positioning and utilitarian incision 
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Surgical technique
The surgical technique for en bloc resection of the proximal fibula 
was performed as described by Malawer in 1984.3 A marginal 
excision of the proximal fibula is described as a type I and a wide 
intra-compartmental resection as a type II resection. 
The patient is placed in a semi-supine position, with a sandbag 
under the ipsilateral buttock. This allows access to the anterior 
and lateral compartments, the popliteal space and the posterior 
compartment when the knee is flexed.3 It is prudent to prepare the 
limb for an above-knee amputation in the event that resection is 
not possible with a large and aggressive lesion. A single utilitarian 
anterolateral incision is used which includes the biopsy site and 
tract with an ellipse of surrounding skin. Placement of the biopsy 
site is therefore crucial (Figure 3).
Type I resections include the proximal fibula with 2–3 cm of normal 
diaphysis and a thin cuff of muscle in all dimensions (Figure 4 – red 
marker). The peroneal nerve and motor branches are preserved. 
The anterior tibial artery is sacrificed if necessitated by tumour 
extent. The artery is sacrificed in type II resections, but may be 
preserved in type I resections. The tibiofibular joint is excised intra-
articularly. Reconstruction of the lateral collateral ligament (LCL) 
and biceps femoris tendon (BT) is to the proximal tibia, remaining 
soft tissue or anterolateral capsule, with the knee flexed at 30°. This 
may be achieved either with drill holes or the use of a bone anchor.
Type II resections (Figure 4 – yellow marker) include the proximal 
fibula and 6–7 cm of normal diaphysis, the proximal anterior and 
lateral muscle compartments, the proximal flexor hallucis longus 
(FHL) and tibialis posterior (TP) muscles, the anterior tibial artery, 
the peroneal nerve, and if required, the peroneal artery. The 
tibiofibular joint is resected extra-articularly with resection of the 
lateral tibial cortex and a variable portion of its metaphysis. Soft 
tissue reconstruction involves fixing the LCL and BT to the proximal 
tibia. The lateral gastrocnemius muscle is rotated to cover the 
surgical defect and exposed tibia. The muscle is released from the 
medial belly in the midline and distally as it joins the soleus.
Post-operative rehabilitation included three weeks of 
immobilisation at 30° of flexion. Full weight bearing was allowed 
as tolerated. An ankle–foot orthosis was prescribed for type II 
resections if required. Some authors2,12 use a knee immobiliser for 
six weeks, during which motion exercises are started in the last 
two weeks.
Results
Six patients had a type I resection and eight a type II resection. 
The median follow-up period was 38 (6–123) months overall. 
The median follow-up for type I resections was 20 months and 
for type II was 47.5 months. Both groups had no recurrences or 
metastases. There were no wound or vascular complications. The 
characteristics of the patients and the MSTS score at follow-up are 
shown in Tables I and II.
Figure 4. Axial MRI (T1-weighted) depicting the difference between 
type I (red) and type II (yellow) resections. Note type I resections include 
preservation of peroneal nerve, anterior, lateral and deep posterior 
muscular compartments with resection through the tibio-fibular joint. Type 
II resections sacrifice the anterior tibial artery, proximal portions of tibialis 
anterior, extensor hallucis longus, extensor digitorum longus, the peroneii 
muscles, FHL and TP muscles and include a shark-bite resection of the 
lateral cortex of the proximal tibia. The peroneal artery and nerve are 
resected as required.
Table I: Patients with type I resection
Patient Sex Age at time of surgery (years) Histology MSTS score
1 Male 32 Chondroblastoma 29
2 Female 53 Chondrosarcoma 30
3 Female 60 GCT 29
4 Male 53 GCT 15
5 Male 17 GCT 30
6 Female 14 Osteochondroma 28
Table II: Patients with type II resection
Patient Sex Age at time of surgery (years) Histology Huvos score MSTS score
1 Female 13 Osteoblastic osteosarcoma 90% 25
2 Male 10 Osteoblastic osteosarcoma 100% 24
3 Male 6 Ewing’s sarcoma 100% 26
4 Male 18 Osteoblastic osteosarcoma 25% 26
5 Female 83 Leiomyosarcoma 60% 24
6 Female 11 Osteoblastic osteosarcoma 0% 30
7 Male 11 Osteoblastic osteosarcoma 95% 27
8 Male 18 Osteoblastic osteosarcoma 95% 27
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Type I
The median age for type I resections was 42.5 (14–60) years. The 
commonest tumour was giant cell tumour (GCT) in three patients 
(50%) and one each of an osteochondroma, chondrosarcoma and 
chondroblastoma. 
The median MSTS functional score was 29 (15–30). No patients 
in the type I resection group required further surgical intervention. 
Type II 
The median age for type II resections was 12 (6–83) years, with seven 
of the eight patients being under 20 years of age at presentation. 
All the tumours were stage IIB. Osteoblastic osteosarcoma was 
the most common tumour (75%). The remaining two patients were 
Ewing’s sarcoma and leiomyosarcoma.
The median Huvos score was 92.5% (0–100%). Five patients 
achieved ≥90% necrosis of the resected tumour after neo-adjuvant 
chemotherapy, two of which demonstrated 100% necrosis. The 
remaining three patients were alive without disease at their last 
follow-up (range 35–96 months). All patients achieved clear margins 
at initial surgery, and none required a secondary oncological 
procedure. 
All patients reported good MSTS functional scores despite 
resection of the common peroneal nerve in all patients. The median 
score was 26 (24–30). One patient required a tibialis posterior 
tendon transfer (TPTT) for the management of an equinovarus 
foot following resection. His MSTS score post-TPTT was 26. Of the 
remaining seven patients, six required an AFO.
Discussion
The more common Enneking sub-types of neoplasms found in this 
location include benign aggressive and malignant stage IIB lesions. 
Dahlin13 noted that the most common tumours in this location 
include GCT, osteogenic osteosarcoma and Ewing’s sarcoma. In 
our study, similar to that of Abdel et al.2 and Dahlin,13 GCT was 
the commonest tumour (50%) and osteogenic osteosarcoma the 
commonest tumour (75%) undergoing type I and II resections 
respectively. For this reason and due to the crowded anatomy 
of the region, above-knee amputations were advised as the best 
oncological surgical option before 1980.4 However, with the onset 
of limb-sparing surgery the anatomy and resection techniques 
were revisited.3,5-9 The main concerns associated with proximal 
fibula resections are recurrence, post-operative knee instability, 
peroneal nerve palsy, and vascular insufficiency.2
The most important prerequisite of limb salvage is that the 
patient must be left with a limb of better or equal function than 
that of an amputation.14 In resections of the proximal fibula, ligation 
of two of the three major vessels, which is required in a type II 
resection, is compatible with a functional extremity, even in elderly 
patients with peripheral vascular disease.3,15 Previously biplanar 
angiography was recommended by Hudson et al.16, and Marcove 
and Jensen.17 MRI is currently used to identify the involvement, 
location of displaced vessels and the aberrant lack of the posterior 
tibial artery, which can occur in approximately 5% of cases.3 In 
the scenario of an absent posterior tibial artery, an above-knee 
amputation would be indicated. Other contra-indications to limb 
salvage include extension of the tumour intra-articularly into the 
knee and direct tibial involvement.
We had no vascular complications. This may be because only 
one of our patients was over 20 years of age (83 years).
Limb salvage must not compromise oncological outcome, as 
margins are all important for prognosis in high-grade malignant 
sarcomas of bone. An involved margin at resection increases 
the morbidity for the patient necessitating re-excision, possible 
amputation or post-operative radiotherapy. The attainment of a clear 
margin in resections of the proximal fibula is not straightforward. 
Malawer3 describes the direct invasion and serpiginous spread of 
stage IIB tumours along the multiple musculotendinous junctions 
of the surrounding muscles that originate off the fibular head and 
proximal shaft. This is in contrast to the pushing border that is 
more commonly seen with IIB tumours in other sites of the body. 
This may be due to the lack of fascial containment in this area and 
the relatively thin cortex of the fibula. The close proximity of the 
tibiofibular joint to the origin of these tumours leads to invasion of 
the tibiofibular joint by the aggressive sarcomas. This joint, along 
with its capsule and adjacent tibial cortex, must be included in the 
type II resections to attain a wide margin. 
In the study by Abdel et al.2 local recurrence occurred in three 
of 24 patients (13%) who had a type II resection and the post-
operative rate of metastases was 50% for all 112 patients. Our study 
had a 100% negative margin rate in all high-grade tumours with 
no recurrences. We attribute this oncological success to ensuring 
adequate margins and by not attempting to preserve the common 
peroneal nerve where margins are doubtful. 
Abdel et al.2 also report a high local recurrence rate in six of 29 
(21%) patients who had a type I resection for malignant tumours, 
especially osteosarcoma and chondrosarcoma. Although they do not 
note the Enneking staging10 for each tumour type, they recommend 
a type II resection for osteosarcoma and chondrosarcoma. We 
agree that a high-grade sarcoma with an extraosseous component 
warrants a type II resection, but for a low-grade intra-osseous 
chondrosarcoma, a type I resection is adequate.
In benign aggressive tumours intralesional curettage has a 
recurrence rate of 50–100%,12,18 which supports a type I resection 
for these tumours. This differs from Enneking10,11 who advises 
intralesional curettage with an adjuvant with or without bone graft. 
The better results with a type I resection may be due to the unique 
anatomy of this area.
The Huvos scoring system evaluates the histology of the 
tumour post resection by grading the extent of necrosis relative 
to the percentage of residual viable tumour. The scoring system 
has been shown to be useful in prognosis and in the adjuvant 
chemotherapeutic management of both osteogenic osteosarcoma 
and Ewing’s sarcoma.7 In our series of type II resections, 62.5% (n=5) 
of the patients achieved more than 90% necrosis, which, together 
with negative margins, contributed to their good outcomes. The 
remaining three patients in this group were alive without disease 
at their last follow-up. Their follow-up periods were 35, 47 and 96 
months respectively. 
Despite the sacrifice of the common peroneal nerve, all the 
patients who underwent type II resection reported a good functional 
outcome. Inatani et al.18 reiterate this with their report of a mean 
MSTS score of 20 (65%) with sacrifice of the common peroneal 
nerve. In our series of type II resections the median MSTS score 
was 26. Naturally in our type I resections, where a wide margin 
can be taken safely with preservation of the nerve, the median 
functional score improves to 29. 
Only one patient required a TPTT for the management of an 
equinovarus foot. The patient had a good functional outcome with 
a MSTS score of 27. None of the other type II resection patients 
underwent this procedure and had equivalent scores, although six 
of the seven patients required an ankle–foot orthosis (AFO).
Peroneal nerve palsy has been described as a complication 
despite attempts at nerve preservation. In the paper by Abdel et 
al.2, two of 29 (7%) patients suffered a palsy where the peroneal 
nerve was spared during a type I resection. The incidence in the 
literature varies between 20% and 57%.3,7,14
Type I and type II resections include sacrificing adjacent knee 
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stabilising structures. Unlike traumatic disruption of the lateral 
ligamentous structures, their reconstruction is controversial. 
Reconstruction of the biceps femoris tendon (BT) and lateral 
collateral ligament (LCL) is performed by some authors; however, 
Einoder et al.19 believe that the reconstruction of the transected 
tendon and ligament is unnecessary as the integrity of the posterior 
capsule and other supporting structures such as the cruciate 
ligaments still remains. In their study however, the patients remained 
in a hinged knee brace for three months. Other authors2,12,18 advised 
BT and LCL reconstruction. In two of these studies,2,12 83 knees 
were examined with a varus stress test at 30° of knee flexion. No 
patient had more than grade 2 instability. We did not examine our 
patients formally with a varus stress test but no patient subjectively 
complained of instability.
There were no wound complications found in this study. Wound 
dehiscence, haematoma and flap necrosis can be prevented with a 
primary lateral gastrocnemius flap in type II resections. The rotated 
gastrocnemius belly also fills the defect created by resection of the 
proximal anterolateral muscles and fibula, and results in a more 
cosmetically acceptable shaped leg. Unfortunately, this causes 
delay in post-operative adjuvant oncological treatment, as the 
surgical wound requires time to heal before treatment is given. 
Synovial fistula was not seen in our study and was seen in only one 
of ten patients in Malawer’s3 original study. This complication can 
be prevented by meticulous closure of the posterior capsule and 
immobilising the knee in 30° of flexion for three weeks. 
This study is subject to the bias of a retrospective study. We 
had small numbers. It must be noted that this is a rare group of 
tumours and a smaller subset has been selected. Even in Abdel’s 
paper2, which spanned 97 years, they amassed only 112 patients 
with malignant tumours, of whom less than half (n=53) underwent 
limb-sparing surgery and even fewer (n=24) type II resections. We 
did not assess knee instability formally.
Conclusions
To achieve a favourable outcome, the biopsy technique is important 
and must be carried out to involve only one compartment; usually 
anterolaterally within the utilitarian incision to allow a 2–3 cm 
ellipse of skin with its tract to be included in the excision. Close but 
safe margins are achievable with the correct technique, and vital 
structures are retained as much as possible.
Our recommendations when faced with a lesion in the proximal 
fibula would depend on its histological diagnosis and Enneking 
staging.10 Benign latent lesions should be managed conservatively 
with observation, while benign active lesions should be addressed 
with intra-lesional resection. A very large active lesion, such as 
the osteochondroma in our study, may require a type I Malawer 
resection. Benign aggressive lesions, such as GCTs, and 
malignant tumours without extra-osseous spread, such as the 
chondrosarcoma in our study, should be excised en bloc using the 
type I Malawer resection. All malignant stage IIB tumours, i.e. with 
extra-osseous extension, should be treated with a type II Malawer 
resection with no attempt to spare the common peroneal nerve. 
This is to ensure a good oncological result with a functionally 
acceptable limb.
Resection of malignant and benign tumours of the proximal 
fibula in this series achieved good cure rates and functional results, 
with or without the aid of an orthosis, despite the sacrifice of the 
common peroneal nerve in type II resections.
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